Apofri Diklofenak 23,2 mg/g gel

Apofri Diklofenak 23,2 mg/g is an over-the-counter anti-inflammatory and pain-relieving gel designed to alleviate local pain and swelling associated with muscle and joint injuries, such as sprains and strains.

The Apofri brand was established in Sweden in 2011 by Apoteksgruppen as a private-label range offering high-quality non-prescription pharmaceuticals, skincare, and everyday healthcare essentials. Apoteksgruppen was later acquired by Euroapotheca, an international healthcare and pharmacy retail group headquartered in Vilnius, Lithuania, which subsequently merged its Swedish pharmacy operations with Kronans Apotek under a joint venture ownership structure (Doktorse Nordic AB / Orion Partners / Euroapotheca).

Like many generic pharmaceuticals, production is contracted out to certified European pharmaceutical manufacturers, with packaging and manufacturing locations varying across batches.